Compounds > perifosine
Page last updated: 2024-09-04

perifosine and Angiogenesis, Pathologic

perifosine has been researched along with Angiogenesis, Pathologic in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carlo-Stella, C; Cleris, L; Daidone, MG; Giacomini, A; Gianni, AM; Locatelli, SL; Mitola, S; Righi, M1
Cho, KJ; Han, KH; Kim, da Y; Kim, DY; Kim, MN; Lim, HY; Park, JH; Ro, SW1
Cseh, A; Szalay, B; Szebeni, B; Vásárhelyi, B1
Chinn, DC; Gandara, DR; Holland, WS; Lara, PN; Mack, PC; Pietri, JE; Tepper, CG1
Fei, HR; Li, XQ; Shi, R; Wang, de C; Wang, FZ1
Belden, CJ; Fadul, CE; Harris, BT; Israel, MA; Pastel, DA; Paulsen, K; Ran, C; Roberts, DW; Valdes, PA1

Reviews

1 review(s) available for perifosine and Angiogenesis, Pathologic

ArticleYear
Genetics of glioblastoma: a window into its imaging and histopathologic variability.
    Radiographics : a review publication of the Radiological Society of North America, Inc, 2011, Volume: 31, Issue:6

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Proliferation; Cell Survival; Erlotinib Hydrochloride; Gefitinib; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Magnetic Resonance Imaging; Neoplasm Invasiveness; Neovascularization, Pathologic; Phosphorylcholine; Protein Kinase Inhibitors; Quinazolines

2011

Other Studies

5 other study(ies) available for perifosine and Angiogenesis, Pathologic

ArticleYear
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells.
    Angiogenesis, 2013, Volume: 16, Issue:3

    Topics: Analysis of Variance; Animals; Antigens, CD34; Blotting, Western; Cell Line, Tumor; DNA Primers; Endothelial Cells; Female; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation; Hematopoietic Stem Cell Transplantation; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Inbred NOD; Mice, SCID; Microscopy, Confocal; Neovascularization, Pathologic; Phosphorylcholine; Receptors, TNF-Related Apoptosis-Inducing Ligand; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand

2013
Efficacy of perifosine alone and in combination with sorafenib in an HrasG12V plus shp53 transgenic mouse model of hepatocellular carcinoma.
    Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cell Proliferation; DNA Transposable Elements; Drug Synergism; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Phosphorylcholine; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins p21(ras); RNA, Small Interfering; Sorafenib; Tumor Suppressor Protein p53

2015
[Akt enzyme: new therapeutic target in cancer and diabetes?].
    Orvosi hetilap, 2009, Feb-22, Volume: 150, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Diabetes Mellitus; Enzyme Activation; Humans; Hypoglycemic Agents; Insulin Resistance; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Ribonucleosides

2009
Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapy.
    Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Interleukin-8; Kidney Neoplasms; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Phosphorylation; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Sirolimus; TOR Serine-Threonine Kinases

2012
Perifosine as potential anti-cancer agent inhibits proliferation, migration, and tube formation of human umbilical vein endothelial cells.
    Molecular and cellular biochemistry, 2012, Volume: 368, Issue:1-2

    Topics: Antineoplastic Agents; Cell Line; Cell Movement; Cyclin B1; G2 Phase; Human Umbilical Vein Endothelial Cells; Humans; Neovascularization, Pathologic; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Vascular Endothelial Growth Factor A

2012